Recent Updates
Recently added Catalysts
SMMT Negative Sentiment

Presented by Dr. Li Zhang, ASCO 2024 Presented by Dr. Li Zhang, ASCO 2024 Presented by Dr. Li Zhang, ASCO 2024 Presented by Dr. Li Zhang, ASCO 2024 Presented by Dr. Li Zhang, ASCO 2024 Presented by Dr. Li Zhang, ASCO 202

Monday, June 3, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: The article primarily repeats the phrase 'Presented by Dr. Li Zhang, ASCO 2024' numerous times without providing any specific details or insights about the event. This lack of content results in a failure to convey meaningful news or analysis related to the presentation or the conference. Consequently, readers are left without any valuable information regarding advancements or discussions expected at ASCO 2024.
Price reaction · baseline $8.685 (2024-05-31 close) · clean, no other SMMT news in the window
day 0 close
+1.8%
day 1 · peak
-15.9%
day 3
-6.4%

Market Sentiment Analysis

CONCERNS & RISKS

  • The article contains repetitive phrases and lacks substantive content.
  • There is no informative or analytical content provided regarding ASCO 2024.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+1236%
120-day peak, hindsight
Typical move
47.7%
average across 2 past catalysts
Cash runway
~14 mo
Low dilution risk
Lead asset
Ivonescimab
Phase 3 · Non-Small Cell Lung Cancer

Full Press Release Details

Presented by Dr. Li Zhang, ASCO 2024
Presented by Dr. Li Zhang, ASCO 2024
Presented by Dr. Li Zhang, ASCO 2024
Presented by Dr. Li Zhang, ASCO 2024
Presented by Dr. Li Zhang, ASCO 2024
Presented by Dr. Li Zhang, ASCO 2024
Presented by Dr. Li Zhang, ASCO 2024
Presented by Dr. Li Zhang, ASCO 2024
Presented by Dr. Li Zhang, ASCO 2024
Presented by Dr. Li Zhang, ASCO 2024
Presented by Dr. Li Zhang, ASCO 2024
Presented by Dr. Li Zhang, ASCO 2024
Presented by Dr. Li Zhang, ASCO 2024
Presented by Dr. Li Zhang, ASCO 2024
Presented by Dr. Li Zhang, ASCO 2024
Presented by Dr. Li Zhang, ASCO 2024
Presented by Dr. Li Zhang, ASCO 2024
Presented by Dr. Li Zhang, ASCO 2024
Presented by Dr. Li Zhang, ASCO 2024

Frequently Asked Questions

Who presented at ASCO 2024?

Dr. Li Zhang presented at ASCO 2024.

How many times was Dr. Li Zhang presented at ASCO 2024?

Dr. Li Zhang's presentation was mentioned multiple times.

What event did Dr. Li Zhang participate in?

Dr. Li Zhang participated in ASCO 2024.

Is Dr. Li Zhang's presentation highlighted?

Yes, the presentation is highlighted repeatedly.

ShareAdd on Google
Tags: SMMT Viatris Investor Conferences Healthcare ASCO 2024 Dr. Li Zhang biopharma cancer research
Last updated: Jun 3, 2024

Biotech snapshot

Cash runway
$691M liquidity · $47M/mo burn
~14 mo
Low dilution risk
Lead asset
IvonescimabPhase 3
Non-Small Cell Lung Cancer →

Catalyst track record

+1236%
best trade around SMMT's most recent catalyst

Peak hindsight return over a 120-day window, across 2 tracked FDA/PDUFA catalysts for SMMT.

See every catalyst's timing & PoA →